UPLC-Q-TOF-MS-based unbiased serum metabolomics investigation of cholangiocarcinoma
This study identifies novel metabolic biomarkers for the early diagnosis of CCA and provides a deeper understanding of the metabolic alterations associated with the disease. These findings could contribute to the development of diagnostic strategies and therapeutic interventions for CCA.
Authors
- Yuanhong Xu (ORCID: https://orcid.org/0000-0002-1637-3800)
- Jia Ran
- Xiaowei Wang (ORCID: https://orcid.org/0000-0002-9427-3477)
- Xuefeng Xu (ORCID: https://orcid.org/0000-0003-1844-3224)
- Ping Hu (ORCID: https://orcid.org/0000-0003-0865-8993)
Institutions
- East China University of Science and Technology (CN)
- Anhui Medical University (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- Frontiers in Molecular Biosciences
- Published
- 2025-04-07
- DOI
- https://doi.org/10.3389/fmolb.2025.1549223
- Citations
- 2
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.01